Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
23,051,868
-
Share change
-
+3,608,301
-
Total reported value
-
$363,615,000
-
Price per share
-
$15.78
-
Number of holders
-
56
-
Value change
-
+$53,059,884
-
Number of buys
-
38
-
Number of sells
-
19
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q4 2018
As of 31 Dec 2018,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,051,868 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, JENNISON ASSOCIATES LLC, UBS Group AG, ORBIMED ADVISORS LLC, Artal Group S.A., FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., and HSBC HOLDINGS PLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.